IEP — Icahn Enterprises L.P.

Icahn Enterprises L.P. Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Net Asset Value (NAV): Increased by $567 million in Q3 2025.
• Energy Segment EBITDA: Consolidated EBITDA reached $625 million, a significant recovery from a loss of $35 million in Q3 2024.
• Automotive Segment: Revenues increased by $11 million year-over-year, with same-store sales up 6%.
• Real Estate Segment: Adjusted EBITDA decreased by $12 million, primarily due to the sale of a country club.
• Food Packaging Segment: Adjusted EBITDA decreased by $8 million due to lower volume and manufacturing inefficiencies.
• Pharmaceutical Segment: Adjusted EBITDA decreased by $7 million, impacted by generic competition.

2. Strategic Updates and Business Highlights:

• CVI Performance: The refining segment's NAV contribution was $547 million, driven by geopolitical factors, increased crack spreads, and the resolution of small refinery exemptions.
• Investment Focus: Significant investments in AEP (electric utility), Southwest Gas, and EchoStar were highlighted, with AEP positioned to benefit from AI infrastructure growth.
• Monroe Investment: A new investment in Monroe, an auto service company, was announced, with expectations of strong growth potential.
• Real Estate Strategy: The transfer of owned properties from the Automotive segment to Real Estate aims to unlock value.

3. Forward Guidance and Outlook:

• CVI Expectations: Continued hope for small refinery exemptions under the Trump administration and EPA.
• Growth Projections: Southwest Gas is expected to grow net income at a 14% CAGR from 2025 to 2029, outpacing peers.
• Pharmaceutical Development: A new drug trial for pulmonary arterial hypertension (PAH) is set to begin in Q1 2026, with potential for significant market impact.

4. Bad News, Challenges, or Points of Concern:

• Declining Segments: Adjusted EBITDA declines in Real Estate, Food Packaging, Home Fashions, and Pharmaceuticals raise concerns about operational efficiency and market competitiveness.
• Caesars Performance: Disappointment with recent performance, although the investment thesis remains unchanged.
• Market Risks: General market conditions and competitive pressures affecting various segments, particularly in pharmaceuticals and consumer staples.

5. Notable Q&A Insights:

• Activism Strategy: Andrew Teno emphasized the company's focus on activist strategies, leveraging the Icahn brand and liquidity to pursue opportunities.
• Long-term View: Despite short-term fluctuations in returns, the management remains optimistic about the long-term value creation for unitholders through strategic activism and investments.

Overall, Icahn Enterprises reported a strong quarter with significant NAV growth and a recovery in the energy segment, while facing challenges in other areas that require ongoing attention and strategic adjustments.